Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:14 PM
Ignite Modification Date:
2025-12-24 @ 7:14 PM
NCT ID:
NCT03609203
Eligibility Criteria:
Healthy Volunteers: must be the friends or relatives of the cancer patients enrolled in this study.
Inclusion Criteria:
* HCT recipients
* Age ≥ 18 years
* Greater than 6 months after completing systemic multiagent chemotherapy (greater than 12 months for HCT participants) at the time of enrollment. Maintenance chemotherapy is allowed
* In remission from cancer Off immunosuppression, or on a stable immunosuppression regimen with prednisone doses ≤ 20 mg daily, with no changes planned to the immunosuppression regimen during the study period
* Karnofsky performance status ≥ 50% (Appendix III)
* Platelet count ≥ 50,000 without transfusions
* Absolute neutrophil count ≥ 1
* Willing to complete weekly strength training sessions for 10 consecutive weeks and complete all pre- and post-testing (self-efficacy survey and research blood draw)
* Currently reside within the Minneapolis-St. Paul metro area
* Has an adult (age ≥ 18) friend or relative who is willing to serve as an exercise partner and healthy control for the study
* If known diabetic: Stable doses of medications to treat diabetes within 4 weeks prior to enrollment
* Willing and able to sign voluntary written consent
* Healthy Controls
* Age ≥ 18 years
* Karnofsky performance status ≥ 50%
* Willing to complete weekly strength training sessions for 10 consecutive weeks and complete all pre- and post-testing (self-efficacy survey and research blood draw)
* Currently reside within the Minneapolis-St. Paul metro area
* If known diabetic: Stable doses of medications to treat diabetes within 4 weeks prior to enrollment
* Willing and able to sign voluntary written consent
Exclusion Criteria for both Cancer Survivors and Controls
* Presence of an external central venous catheter (Hickman, PICC, etc); Port-a-cath devices that are completely internal are allowed
* Use of ≥ 20+ mg prednisone daily
* Current or planned use of investigational drugs during the study period
* Myocardial infarction or stroke within 6 months
* Heart failure graded Class IV on New York Heart Association (NYHA) scale (https://manual.jointcommission.org/releases/TJC2018A/DataElem0439.html)
* Any medical condition that the consenting medical provider deems would make the participant unsafe to perform a 10-week strength training program
* Are currently pregnant
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03609203
Study Brief:
Protocol Section:
NCT03609203